MSACL testimonial from Dr. Michael Lutz

In this video, Thermo Fisher Scientific presents a testimonial from Dr. Michael Lutz, senior advisor at Osteolabs, a diagnostic company specializing in clinical assays for metabolic bone disorders. Dr. Lutz discusses how the use of inductively coupled plasma mass spectrometry (ICP-MS) methods developed by Osteolabs will impact over 1 billion patients with metabolic bone diseases around the world.